Menu Back toTFDA-Town-Hall

DIA 2018 Global Annual Meeting


TFDA Chinese Taipei Town Hall

    Session Chair(s)
      Chao-Yi  Wang, MSc

      Chao-Yi Wang, MSc

      • Director, Division of Medicinal Products, Ministry of Health and Welfare
      • TFDA, Chinese Taipei, Taiwan
    This session will include updates on various initiatives presented by the TFDA, Chinese Taipei.
    Learning Objective : To introduce adjustments to the TFDA’s system in response to new and innovative drugs in global MRCTs. A successful story based on transparency and efficiency with a predictable timeline to promote early access to effective, safe, and high-quality pharmaceutical products in Taiwan and China.
    Speaker(s)
      Chao-Yi  Wang, MSc

      TFDA, Chinese Taipei Perspective on Regulatory Management of Drug Development

      Chao-Yi Wang, MSc

      • Director, Division of Medicinal Products, Ministry of Health and Welfare
      • TFDA, Chinese Taipei, Taiwan
      James Chih-Hsin  Yang, MD, PhD

      Regulatory Challenges in Reviewing MRCT Data: The TFDA, Chinese Taipei Perspective

      James Chih-Hsin Yang, MD, PhD

      • Director, Department of Oncology
      • NTU Hospital, Taiwan
      Yi-Chu  Lin, PhD

      Using Real World Evidence in Regulatory Decision Making

      Yi-Chu Lin, PhD

      • Section Chief, Division of Medicinal Products, Ministry of Health and Welfare
      • TFDA Chinese Taipei, Taiwan
      Annie Tsu-Hui  Liu

      The Development of Biotechnological Medicine in Chinese Taipei

      Annie Tsu-Hui Liu

      • Director, Office of Science and Technology
      • Executive Yuan, Taiwan